Skip to main content
. 2020 Dec 23;23(7):1100–1112. doi: 10.1093/neuonc/noaa298

Fig. 3.

Fig. 3

Outcome per LM type and primary tumor. Distribution per EANO ESMO subtype (A) and survival per subtype (B) in patients with LM from breast cancer, lung cancer or melanoma. Comparisons of subgroups were performed with the log-rank test.